WINDTREE THERAPEUTICS INC /DE/ (WINT) Net Income (Loss) Attributable to Parent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Windtree Therapeutics Inc /De/ Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $10.2 M.
  • Windtree Therapeutics Inc /De/ Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$5.96 M, a 83.1% increase year-over-year.
  • Windtree Therapeutics Inc /De/ annual Net Income (Loss) Attributable to Parent for 2023 was -$20.3 M, a 48.2% increase from 2022.
  • Windtree Therapeutics Inc /De/ annual Net Income (Loss) Attributable to Parent for 2022 was -$39.2 M, a 42% increase from 2021.
  • Windtree Therapeutics Inc /De/ annual Net Income (Loss) Attributable to Parent for 2021 was -$67.6 M, a 108% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$5.96 M $10.2 M +$14.3 M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$20.3 M -$5.15 M +$4.54 M +46.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$24.8 M -$4.43 M -$369 K -9.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$24.5 M -$6.6 M +$10.7 M +61.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-09
Q1 2023 -$35.2 M -$4.11 M +$4.02 M +49.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$39.2 M -$9.69 M +$3.38 M +25.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$42.6 M -$4.06 M +$4.16 M +50.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$46.7 M -$17.3 M +$20.1 M +53.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$66.8 M -$8.13 M +$834 K +9.31% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$67.6 M -$13.1 M -$5.62 M -75.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$62 M -$8.21 M +$807 K +8.95% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$62.8 M -$37.4 M -$27.8 M -291% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$35 M -$8.96 M -$2.43 M -37.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$32.6 M -$7.45 M -$79 K -1.07% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$32.5 M -$9.02 M -$1.89 M -26.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$30.6 M -$9.56 M -$3.12 M -48.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$27.5 M -$6.53 M +$3 K +0.05% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$27.5 M -$7.38 M +$1.67 M +18.4% Oct 1, 2019 Dec 31, 2019 10-K 2020-04-03
Q3 2019 -$29.1 M -$7.13 M -$3.2 M -81.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$25.9 M -$6.44 M -$3.39 M -111% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$22.6 M -$6.54 M -$2.03 M -44.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q4 2018 -$20.5 M -$9.04 M -$11.5 M -466% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-03
Q3 2018 -$9.02 M -$3.93 M +$1.52 M +27.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-04-03
Q2 2018 -$10.5 M -$3.05 M +$3.7 M +54.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-04-03
Q1 2018 -$14.2 M -$4.51 M +$4.21 M +48.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-04-03
Q4 2017 -$18.4 M $2.47 M +$9.08 M Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 -$27.5 M -$5.44 M +$2.92 M +34.9% Jul 1, 2017 Sep 30, 2017 10-K/A 2019-04-23
Q2 2017 -$30.4 M -$6.75 M +$3.87 M +36.4% Apr 1, 2017 Jun 30, 2017 10-K/A 2019-04-23
Q1 2017 -$34.3 M -$8.72 M +$5.18 M +37.2% Jan 1, 2017 Mar 31, 2017 10-K/A 2019-04-23
Q4 2016 -$39.5 M -$6.6 M +$3.51 M +34.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$43 M -$8.36 M +$13.2 M +61.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-17
Q2 2016 -$56.2 M -$10.6 M +$702 K +6.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-17
Q1 2016 -$56.9 M -$13.9 M -$1.72 M -14.1% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-17
Q4 2015 -$55.2 M -$10.1 M +$526 K +4.95% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$55.7 M -$21.6 M -$10.2 M -90.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$45.5 M -$11.3 M -$703 K -6.62% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-31
Q1 2015 -$44.8 M -$12.2 M -$703 K -6.13% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-31
Q4 2014 -$44.1 M -$10.6 M +$1.09 M +9.33% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-03-29
Q3 2014 -$45.2 M -$11.3 M +$900 K +7.36% Jul 1, 2014 Sep 30, 2014 10-K/A 2016-03-29
Q2 2014 -$46.1 M -$10.6 M -$2 M -23.1% Apr 1, 2014 Jun 30, 2014 10-K/A 2016-03-29
Q1 2014 -$44.1 M -$11.5 M +$1.16 M +9.17% Jan 1, 2014 Mar 31, 2014 10-K/A 2016-03-29
Q4 2013 -$45.2 M -$11.7 M -$4.91 M -72.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$40.3 M -$12.2 M +$1.12 M +8.41% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$41.4 M -$8.63 M -$1.49 M -20.9% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$39.9 M -$12.6 M -$2.62 M -26.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$37.3 M -$6.82 M -$2.51 M -58.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-17
Q3 2012 -$34.8 M -$13.3 M -$8.6 M -181% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-17
Q2 2012 -$26.2 M -$7.14 M +$938 K +11.6% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-17
Q1 2012 -$27.1 M -$10 M -$6.18 M -161% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-17
Q4 2011 -$21 M -$4.3 M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$4.75 M +$1.83 M +27.8% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 -$8.08 M -$7.28 M -918% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 -$3.84 M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 -$6.58 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$793 K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.